Sign in

CIK 0001048477

  • Large accelerated filer

BIOMARIN PHARMACEUTICAL INC

Sign in to watch
Ticker
BMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680397820
Phone
+1 415-506-6700
Business address
105 DIGITAL DRIVE, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,163,748
in 1 filing

Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Davis George Eric −$1.2M EVP, Chief Legal Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-15 BIENAIME JEAN JACQUES Chief Executive Officer Shares withheld for taxes −9,437 $87.74 $828K 514,519
2023-03-15 BIENAIME JEAN JACQUES Chief Executive Officer Grant or award · Stock Option (Right to buy Common Stock) +49,430 49,430
2023-03-15 Ajer Jeffrey Robert EVP, Chief Commercial Officer Grant or award +10,110 89,967
2023-03-15 Ajer Jeffrey Robert EVP, Chief Commercial Officer Shares withheld for taxes −3,971 $87.74 $348K 85,996
2023-03-15 Ajer Jeffrey Robert EVP, Chief Commercial Officer Grant or award · Stock Option (Right to buy Common Stock) +23,070 23,070
2023-03-13 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +8,000 $67.81 $542K 495,856
2023-03-13 BIENAIME JEAN JACQUES Chief Executive Officer Sale −8,000 $90.45 $724K 487,856
2023-03-13 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −8,000 149,130
2023-03-10 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +15,000 $67.81 $1.0M 502,856
2023-03-10 BIENAIME JEAN JACQUES Chief Executive Officer Sale −15,000 $92.28 $1.4M 487,856
2023-03-10 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −15,000 157,130
2023-02-28 Mueller Brian EVP, Chief Financial Officer Grant or award +12,660 40,406
2023-02-28 Mueller Brian EVP, Chief Financial Officer Grant or award +10,980 51,386
2023-02-28 Mueller Brian EVP, Chief Financial Officer Grant or award +1,250 52,636
2023-02-28 Davis George Eric EVP, Chief Legal Officer Grant or award +20,200 76,925
2023-02-28 Davis George Eric EVP, Chief Legal Officer Grant or award +10,100 87,025
2023-02-28 Davis George Eric EVP, Chief Legal Officer Grant or award +7,424 94,449
2023-02-28 Ajer Jeffrey Robert EVP, Chief Commercial Officer Grant or award +20,760 61,848
2023-02-28 Ajer Jeffrey Robert EVP, Chief Commercial Officer Grant or award +10,380 72,228
2023-02-28 Ajer Jeffrey Robert EVP, Chief Commercial Officer Grant or award +7,629 79,857

Page 17 of 23 · 450 trades